ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ASND Ascendis Pharma AS

135.10
-2.35 (-1.71%)
01 Jun 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 587,045
Bid Price 131.72
Ask Price 142.19
News (1)
Share Name Share Symbol Market Stock Type
Ascendis Pharma AS ASND NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
-2.35 -1.71% 135.10 08:00:05
Open Price Low Price High Price Close Price Previous Close
139.47 134.845 143.76 135.10 137.45
Trades Shares Traded VWAP Financial Volume Average Volume
7,796 587,045  137.69  80,829,686 -
Last Trade Type Quantity Price Currency
07:04:26 formt 18,719  135.10 USD

Ascendis Pharma AS Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 0.00 - 200.64M -481.45M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Ascendis Pharma AS

Date Time Source Heading
01/6/202406:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/5/202422:30GlobeNewswire Inc.Ascendis to Spotlight Latest Updates for TransCon™ Rare..
30/5/202406:08Edgar (US Regulatory)Form SD - Specialized disclosure report
17/5/202406:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/5/202404:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/5/202404:31GlobeNewswire Inc.Ascendis Pharma Announces Extension of U.S. Food and Drug..
13/5/202422:30GlobeNewswire Inc.Significant and Sustained Improvements in Renal Function..
09/5/202422:30GlobeNewswire Inc.Latest Clinical and Quality-of-Life Data for TransCon™ PTH..
03/5/202406:01GlobeNewswire Inc.Ascendis Pharma Reports First Quarter 2024 Financial Results
26/4/202406:46GlobeNewswire Inc.Ascendis Pharma to Report First Quarter 2024 Financial..
24/4/202422:30GlobeNewswire Inc.United Kingdom’s MHRA Approves YORVIPATH®..
08/3/202403:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securities

ASND Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%